Search Results - jeonghan+kim

1 Results

Sort By:

Use of VDAC inhibitor, VBIT4, as a Treatment for Lupus

This technology includes a small molecule drug (VDAC inhibitor, also known as VBIT4) that may be useful for inhibiting lupus disease. To test lupus animal model, VBIT4 was continuously administered for 5 weeks to mice and there was no mortality or clinical symptoms in these animals. Additionally, VBIT4 treatment blocked the development of skin lesions...

Published: 8/12/2024 | Inventor(s): Jeonghan Kim, Jay Chung, Varda Shoshan-barmatz

Keywords(s):

Category(s): Application > Therapeutics, Collaboration Sought > Licensing, TherapeuticArea > Immunology